MW150

MW150 · Neurokine Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MW150, covering 2022-03-29 to 2022-03-29. Get the full timeline:

Most recent: Clinical Trial Update: MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease [Phase 2]